Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Plus, who said he has cancer? Not him...
This stock will not move until oil prices rise. You have awhile, maybe a few months +....good luck....
From recent video:
1. Closed on a deal
2. New CFO on Monday
3. Alliances put together
4. $200,000 revenue
5. 5 area wells starting (But he stops before giving a date)
6. Expanded 2-3 times overnight
7. Real important news next week
It's obvious what will happen to this stock if there is no PR next week. Just for kicks I'm going with 1-7 above..IMO...Next week will be very interesting on this board.
Yep, actually things are looking really good.
That might be the case, but when JJ separated ESI into a majority owned subsidiary he also relinquished all the patents to ESI, regarding exosomes. Personally, I can't think of one thing that ESI holds that controls the hemopurifier. Maybe you can expand on that. ESI was just for testing tumor secreted Exosomes and to see if the Hemopurifier could collect them. Also, the PRs are always separate and do not mix data, ie ESI working on CTE. There is no connection to the hemopurifier. If there is a major connection I'd like to know. I must be missing something.
That's possible, but I've always thought that JJ was holding ESI for a nice acquisition. They do not need to own ESI to do business with them. Sell ESI and no need for a RS. I believe that's why ESI is a majority owned subsidiary. IMO
Detecting CTE in living individuals will be a major breakthrough and open the door to partnerships. And I'm sure other larger companies will be watching.
Delay on ESI CTE PR and cleaning up. I do not see a RS in the future. Detecting CTE would be a game changer IMO
Thanks for the education on Paradigm and VV. I'll go into the shadows now. Good luck to all.
Yes, wrong wording. I meant the four drilling rigs they were bringing on board. Yes, you can argue everthing, or believe what's been said in recent PRs. besides trash talk on this board I haven't see anything not to believe they are making progress.
We are still awaiting that PR. Should be a good one. New management, new oil rigs, and oil price up.
Wow, you spent too much time on that. Just buy now and you will still be happy. Wrong stock to mess with now.
It's not a long shot. Worse case scenario they announce more rigs open or selling their reserve oil at a higher price then last week. It's all good...
Glad I could make you laugh. Have a great long weekend.
This may be the problem...So we wait?
During a Quiet Period, a publicly listed company cannot make any announcements about anything that could cause a normal investor to change their position on the company's stock. Normally, that means the company does not discuss any of the following:
New deals or wins signed in that current quarter. Announcements about previously sold implementations going live are allowed, but must be explicitly described as such
Management changes
Progress against company goals
Major product or service announcements
Major partnership announcements
All night long...got coffee going? The company is going good. Can't wait to here progress. Great start up company
PR coming soon with new players and more oil rigs. I'm doing this all night because oil price is rising and the company is doing good....Buy...
PR coming out soon. Get in now.....new management and oil rigs... oil going up. It's a win win.
I know. like we all don't know how to play the game. Let it get to .0003 or 0002 0001 and I still load. I've been loading at every drop. And I'm not a P/D. I'm not just going to let them take my money. Actually, I'm good at taking theirs. By the way, PR is coming, enjoy.
Ya please, would you give me his cell number.
CEO'S don't communicate to individual shareholders via email. Especially providing a time or advantage. It's business 101.
I would say that anyone could come up with that analogy if nothing happens. I bet if there was a PR the stock price would rise? Just a guess, what do I know. Good luck on your .0001
And will climb. That's why I'm here....
Why are you even here? This is for investors that know what their doing? Move on to something simple.
Did you say call or email VV? I'd like to see real responses from him. They do not and will not provide info outside PRs.
Why sell barrels for pennies when you can wait for dollars. May be no profit for two months, but worth the wait, 20% increase and climbing. Sounds smart to me if he can hold without going under. He is actually making more money currently by holding his stockpile. IMO when he sells at a higher rate he is back in the game and so are we.
Below was a response from JJ on his chairmans blog. Since they had great results in India I'm guessing they will keep us well posted on their data as it arrives.
James Joyce
February 6, 2015 - 8:56 am
Thank you for your continued support in Aethlon Medical, stay tuned to follow the clinical progression of our Hemopurifier.
- See more at: http://www.thechairmansblog.com/aethlon-medical/james-joyce/launch-clinical-program-re-thinks-treatment-viral-pathogens/#sthash.Axs2t45V.dpuf
This weeks PR is just a foundation for the expected ESI CTE trial PR that's coming. Now that PR should be huge. IMO
Come on....it's way past 48 hours. I do believe they will, but not during a pump. They will wait till it calms down. IMO
350% gain today. I buy back in tomorrow at .0006....watch.
We will see .0004 tomorrow as oil price is going up.
Monday should be a good day, especially if oil prices continue to rise.
Nice oil bounce today...Hope it continues to climb.
http://www.reuters.com/article/2015/01/30/us-markets-oil-idUSKBN0L305Q20150130
Maybe he is not calculating sleep time, which make it another 48 hours once he finally wakes up.
IMO the delay on the FDA IDE Hep C trial is a result of Aethlon being requested again to help an ebola patient.
Dated Nov. 25th.."ROME (AP) — An Italian doctor who contracted Ebola while working in Sierra Leone has arrived back in Italy and is being treated with the same experimental drugs used in the U.S. and other European countries to treat people infected with the virus."
http://www.utsandiego.com/news/2014/nov/25/italys-ebola-patient-gets-experimental-treatment/
Yesterday they announced the Italian doctor worsened and they are awaiting a "new experimental medicine brought in from abroad." Why not just say the drug? They have already tried drugs and have given the doctor two ebola blood transfusions. Obviously, the ebola blood from survivors is not working....What's left to try? My guess is the Hemopurifier, and that would account for the delay on trial news and secrecy. It's also very similar to the German patient as far as treatment options...again all IMO.
Dated Dec. 2nd....
https://www.ansa.it/english/news/science_tecnology/2014/12/02/ebola-patient-suffered-new-deterioration_53e6268e-720a-4924-8142-bea69511db4a.html
I think it's important next week to announce FDA emergency use for ebola and an update to the India study, which would seal the deal. IMO. It would be hard to argue that.
Well when Emory Hospital has a late stage ebola patient I bet they forget their comments and ask for Aethlon.
I believe Helmut Geiger, MD will be presenting from 11:10am to 11:30am tomorrow.
https://www.asn-online.org/education/kidneyweek/2014/program-session-details.aspx?sess_id=656
After tomorrows presentation with hopefully great data, I would assume they have found an ebola therapy that works. It may just be one patient tested, but it comes with real data.
"The vaccine question aside, Fauci said NIH brought together doctors who had cared for the nine Ebola patients treated in the U.S. to look at records of experimental treatments they received.
"It was clear we had no idea what works or what doesn't work," he said, calling that a "strong argument" for clinical trials."
http://abcnews.go.com/Health/wireStory/clinical-trials-tap-ebola-vaccine-26879486
The deliberate delay of data is probably going to come close to the release date for ebola free, Craig Spencer, in New York. Spencer is currently in isolation riding his stationary bike and playing the banjo. I would assume that next week will be Spencer's release and probably around the same time Aethlon holds their public meeting to release data for Michael Mawanda. So, my guess is that we hear good news on two ebola free doctors next week.